Jenburkt Pharmaceuticals Limited Stock

Equities

JENBURPH6

INE354A01013

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:57 2024-07-04 EDT 5-day change 1st Jan Change
878.4 INR -0.02% Intraday chart for Jenburkt Pharmaceuticals Limited +1.53% +29.15%

Financials

Sales 2022 1.24B 14.85M 20.23M Sales 2023 1.37B 16.38M 22.31M Capitalization 2.94B 35.21M 47.96M
Net income 2022 223M 2.67M 3.64M Net income 2023 246M 2.95M 4.01M EV / Sales 2022 1.78 x
Net cash position 2022 398M 4.77M 6.5M Net cash position 2023 466M 5.58M 7.6M EV / Sales 2023 1.81 x
P/E ratio 2022
11.7 x
P/E ratio 2023
11.9 x
Employees 724
Yield 2022
2.12%
Yield 2023
2.16%
Free-Float 38.94%
More Fundamentals * Assessed data
Dynamic Chart
Jenburkt Pharmaceuticals Limited Announces Board Retirements CI
Jenburkt Pharmaceuticals Limited Announces Dividend CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as A Non-Executive and Independent Director CI
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as Non-Executive Independent Director CI
Jenburkt Pharmaceuticals Limited Approves Dividend for the Financial Year Ended 31 March, 2023 CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Jenburkt Pharmaceuticals Limited Approves Dividend CI
Tranche Update on Jenburkt Pharmaceuticals Limited's Equity Buyback Plan announced on December 1, 2022. CI
Jenburkt Pharmaceuticals Limited's Equity Buyback announced on December 1, 2022, has closed with repurchase of 176,078 shares, representing 3.84% for INR 114.24 million. CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Jenburkt Pharmaceuticals Limited announces an Equity Buyback for INR 116 million worth of its shares. CI
More news
1 day-0.02%
1 week+1.53%
Current month+0.69%
1 month+13.21%
3 months+15.59%
6 months+21.75%
Current year+29.15%
More quotes
1 week
845.00
Extreme 845
899.90
1 month
762.60
Extreme 762.6
903.00
Current year
660.05
Extreme 660.05
925.00
1 year
586.90
Extreme 586.9
925.00
3 years
452.00
Extreme 452
925.00
5 years
243.20
Extreme 243.2
925.00
10 years
167.00
Extreme 167
925.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 10-01-07
Director of Finance/CFO 72 13-09-06
Compliance Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 10-01-07
Director of Finance/CFO 72 13-09-06
Director/Board Member 61 20-03-27
More insiders
Date Price Change Volume
24-07-04 878.4 -0.02% 4 306
24-07-03 878.6 -0.19% 1,846
24-07-02 880.2 -0.32% 995
24-07-01 883 +1.22% 4,635
24-06-28 872.4 +0.83% 1,749

Delayed Quote Bombay S.E., July 04, 2024 at 06:00 am

More quotes
Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and health care products. The Company offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The Company's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The Company's manufacturing plant is located in Sihor-Gujarat. The Company's products are exported to approximately 13 countries globally.
More about the company
  1. Stock Market
  2. Equities
  3. JENBURPH6 Stock